Expression of cytokeratin 20 in the blood of patients with disseminated carcinoma of the pancreas, colon, stomach, and lung

Cancer

Volumn 86, Issue 11, 1999, Pages 2398-2405

  Chausovsky, Genady ^a   Luchansky, Michael ^a   Figer, Arie ^b   Shapira, Jeremy ^a   Gottfried, Maya ^a   Novis, Bentley ^a   Bogelman, Galina ^a   Zemer, Ruth ^a   Zimlichman, Shulamit ^a   Klein, Ami ^a  

^a MEIR MEDICAL CENTER   (Israel)

^b RABIN MEDICAL CENTER   (Israel)

Author keywords

Biomarker; Blood; Cytokeratin 20; Metastasis

Indexed keywords

CYTOKERATIN 20; TUMOR MARKER;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; BLOOD LEVEL; COLON CARCINOMA; CONTROLLED STUDY; DISSEMINATED CANCER; HUMAN; HUMAN TISSUE; LUNG CARCINOMA; MAJOR CLINICAL STUDY; METASTASIS; PANCREAS CARCINOMA; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STOMACH CARCINOMA;

EID: 12944275680     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19991201)86:11<2398::AID-CNCR30>3.0.CO;2-5     Document Type: Article

References (14)

1. Moll R, Franke WW, Schiller DL. The catalog of human cytokeratins: patterns of expression in normal epithelia, tumors and cultured cells. Cell 1982;31:11-24.
2. Burchill SA, Bradbury FM, Smith B, Lewis IJ, Selby P. Neuroblastoma cell detection by reverse transcriptase-polymerase chain reaction (RT-PCR) for tyrosine hydroxylase mRNA. Int J Cancer 1994;57:671-5.
3. Smith B, Selby P, Southgate J, Pittman K, Bradley C, Blair GE. Detection of melanoma cells in peripheral blood by means of reverse transcriptase and polymerase chain reaction. Lancet 1991;338:1227-9.
4. Saito S. Detection of H-ras gene point mutations in transitional cell carcinoma of human urinary bladder using polymerase chain reaction. Keio J Med 1992;41:80-6.
5. Klein A, Zemer R, Buchumensky V, Klaper R, Nissenkoren I. Expression of cytokeratin 20 in urine of patients with bladder carcinoma. Cancer 1998;82:349-54.
6. Moll R, Lowe A, Laufer J, Franke WW. Cytokeratin-20 in human carcinomas. A new histodiagnostic marker detected by monoclonal antibodies. Am J Pathol 1992;140:427-47.
7. Moll R, Zimbelmann R, Goldscmidt MD, Keith M, Koch PJ, Franke WW. The human gene encoding cytokeratin 20 and its expression during fetal development in gastrointestinal carcinoma. Differentiation 1993;53:75-93.
8. Ascoli V, Taccogna S, Sclazo CC, Nardi F. Utility of cytokeratin 20 in identifying the origin of metastatic carcinomas in effusions. Diagn Cytopathol 1995;12:303-8.
9. Burchill SA, Bradbury MF, Pittman K, Southgate J, Smith B, Selby P. Detection of epithelial cancer cells in peripheral blood by reverse transcriptase-polymerase chain reaction. Br J Cancer 1995;71:278-81.
10. Funaki NO, Tanaka A, Kasamatsu T, Oshio G, Onodera H, Monden K, et al. Detection of colorectal carcinoma cells in circulating peripheral blood by reverse transcription-polymerase chain reaction targeting cytokeratin mRNA. Life Sci 1997;60:643-52.
11. Osborne M, Weber K. Tumor diagnosis by intermediate filament typing: a novel tool for surgical pathology. Lab Invest 1983;48:372-94.
12. Cooper D, Schermer A, Sun TT. Classification of human epithelia and their neoplasms using monoclonal antibodies to keratins: strategies, applications and limitations. Lab Invest 1985;52:243-56.
13. Lane EB, Alexander CM. Use of keratin antibodies in tumor diagnosis. Semin Cancer Biol 1990;1:165-79.
14. Suo Z, Holm R, Nesland JM. Squamous cell carcinomas. An immunohistochemical study of cytokeratins and involucrin in primary and metastatic tumors. Histopathology 1993;23:45-54.